Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin‐1β in neurodegeneration
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Recent studies have demonstrated the activation of caspase‐1 and caspase‐3 in mice expressing mutant superoxide dismutase 1 (SOD1), models of amyotrophic lateral sclerosis. Caspase‐1 converts the prointerleukin‐1β into a potent proinflammatory molecule involved in the innate immune response and in neurodegenerative diseases. We report on the chronic expression of interleukin‐1β mRNA in the spinal cord of SOD1 G37R mice, together with robust mRNA expression for the nuclear factor‐κB (NF‐κB) inhibitor IκBα, for other proinflammatory cytokines and chemokines (interleukin‐6, tumor necrosis factor‐α, monocyte chemoattractant protein‐1) and for the toll‐like receptor TLR2 involved in innate immunity. To further assess the interleukin‐1β contribution to neurodegeneration, we generated mice expressing SOD1 G37R in a context of interleukin‐1β gene knockout. Surprisingly, the absence of interleukin‐1β had no effect on the life span of SOD1 G37R mice, nor on the extent of motor axon degeneration at age 7 and 10 months. Whereas neither compensatory induction of the interleukin‐1α mRNA nor increases in mRNA levels for IκBα, tumor necrosis factor‐α and macrophage chemoattractant protein‐1 occurred as a result of interleukin‐1β gene disruption, enhanced levels of TLR2 mRNA were detected in SOD1 G37R mice lacking interleukin‐1β. We conclude that interleukin‐1β does not directly contribute to motor neuron degeneration in SOD1 G37R mice, but it may act as a modulator of the innate immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096 · cited 4×
“of IL-1b inhibits reoutgrowth processes and promotes neurodegeneration.(27) For instance, high levels of IL-1b”
BackgroundInfluentialHerx, L. M., Rivest, S., & Yong, V. W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2232 · Cited by 190
Self-citation
Cited by
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Systemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027
Does neuroinflammation fan the flame in neurodegenerative diseases?
Frank-Cannon, T. C., Alto, L. T., McAlpine, F. E., & Tansey, M. G. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-47 · Cited by 751
Innate immunity: the missing link in neuroprotection and neurodegeneration?
Nguyen, M. D., Julien, J.-P., & Rivest, S. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn752 · Cited by 701
Self-citationNeuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease
Philips, T., & Robberecht, W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70015-1 · Cited by 646
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638
“…to globally eliminate single inflammatory genes in ALS mouse models have largely failed to extend survival (Almer et al., 2006; Gowing et al., 2006; Nguyen et al., 2001; Son et al., 2001) and in some cases have even hastened disease progression (Lerman et al., 2012), highlighting the complexity of…”
Targeting programmed cell death in neurodegenerative diseases
Vila, M., & Przedborski, S. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1100 · Cited by 546
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
TURNER, B., & TALBOT, K. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.001 · Cited by 496
Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis
Meissner, F., Molawi, K., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002396107 · Cited by 318
Role of Microglia TLRs in Neurodegeneration
Fiebich, B. L., Batista, C. R. A., Saliba, S. W., Yousif, N. M., & de Oliveira, A. C. P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00329 · Cited by 291
Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model
Guttenplan, K. A., Weigel, M. K., Adler, D. I., Couthouis, J., Liddelow, S. A., Gitler, A. D., & Barres, B. A. (2020) · Nature Communications · doi:10.1038/s41467-020-17514-9 · Cited by 278
Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis
Hooten, K. G., Beers, D. R., Zhao, W., & Appel, S. H. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0329-3 · Cited by 275
Martin, L. J., Liu, Z., Chen, K., Price, A. C., Pan, Y., Swaby, J. A., & Golden, W. C. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21160 · Cited by 269
Caspase-1: is IL-1 just the tip of the ICEberg?
Denes, A., Lopez-Castejon, G., & Brough, D. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.86 · Cited by 265
Appel, S. H., Beers, D. R., & Henkel, J. S. (2010) · Trends in Immunology · doi:10.1016/j.it.2009.09.003 · Cited by 256
“Numerous studies of mSOD1 mice also suggest immune activation of microglia with increased iNOS expression, NOX2 expression, IL-10 expression, and increased IL-6, TNFα, and CCL2 expression [60-65].”
BackgroundNguyen, M. D., D'Aigle, T., Gowing, G., Julien, J.-P., & Rivest, S. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4786-03.2004 · Cited by 248
“The SOD1 G37R mice treated with vehicle (n 16) used as control exhibited an average life span of 49.4 2.7 weeks and a median life probability of 49.0 weeks, which is not different from the life span of the nontreated SOD1 G37R mice (Nguyen et al., 2000, 2001a).”
BackgroundMethodSelf-citationThe microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins
Deora, V., Lee, J. D., Albornoz, E. A., McAlary, L., Jagaraj, C. J., Robertson, A. A. B., Atkin, J. D., Cooper, M. A., Schroder, K., Yerbury, J. J., et al. (2020) · Glia · doi:10.1002/glia.23728 · Cited by 245
Endo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., Sobue, G., Dezawa, M., Wyss-Coray, T., & Yamanaka, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.053 · Cited by 207
“For example, some studies showed that deletion of TNF-a or IL-1b has marginal effects on the survival time of mutant SOD1 mice, while one study showed extended survival of IL-1b-deficient SOD1 mice (Gowing et al., 2006; Meissner et al., 2010; Nguyen et al., 2001).”
ResultMicroglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis
Sargsyan, S. A., Monk, P. N., & Shaw, P. J. (2005) · Glia · doi:10.1002/glia.20210 · Cited by 203
“The role of another cytokine, IL-1b, secreted after activation of p38MAPK, has been proposed to be insignificant in neuronal death in ALS mouse models, as IL-1b knockout had no effect on the life span or degree of motor neuron degeneration in hmSOD1 G37R transgenic mice (Nguyen et al., 2001).”
BackgroundKiaei, M., Kipiani, K., Petri, S., Chen, J., Calingasan, N. Y., & Beal, M. F. (2005) · Neurodegenerative Diseases · doi:10.1159/000090364 · Cited by 199
Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response
Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190
Self-citationJeong, S. Y., Rathore, K. I., Schulz, K., Ponka, P., Arosio, P., & David, S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5443-08.2009 · Cited by 174
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
“Deletion of Il1bextended lifespan and partially rescued motor neuron death of SOD1G93A mice (Meissner et al., 2010), but not SOD1G37R mice (Nguyen et al., 2001).”
BackgroundNon-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147
Gravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117
Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis
Italiani, P., Carlesi, C., Giungato, P., Puxeddu, I., Borroni, B., Bossù, P., Migliorini, P., Siciliano, G., & Boraschi, D. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-94 · Cited by 103
The contribution of the peripheral immune system to neurodegeneration
Berriat, F., Lobsiger, C. S., & Boillée, S. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01323-6 · Cited by 87
Gowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53
Self-citation
Metadata
- Authors
- Nguyen, M. D., Julien, J., & Rivest, S.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2001-10-08
- Volume
- 50
- Issue
- 5
- Pages
- 630-639
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2037939651
- Cited by
- 129
- References
- 3
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.